Sweat Analysis as Prognosticator After Heart Attack (NCT05843006) | Clinical Trial Compass
CompletedNot Applicable
Sweat Analysis as Prognosticator After Heart Attack
Sweden24 participantsStarted 2022-03-21
Plain-language summary
This study characterizes non-invasive body inflammation response in sweat and blood of patients suffering from acute myocardial infarction and explores the potential of non-invasive sweat analysis a an innovative approach for predicting patient outcome.
Who can participate
Age range45 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Study participants will be recruited among subjects referred to Hospital for coronary angiography/PCI due to ST-segment elevation myocardial infarction (STEMI) or diagnostic coronary angiography.
Subjects with a diagnosis of STEMI as defined by chest pain suggestive for myocardial ischemia for at least 30 minutes before hospital admission, time from onset of symptoms of less than 24 hours, and an ECG with new ST-segment elevation in two or more contiguous leads of ≥0.2 mV in leads V2-V3 and/or ≥0.1 mV in other leads or a probable new-onset left bundle branch block
Or:
Subjects undergoing a diagnostic coronary angiography without a resulting intervention (PCI)
and:
Written informed consent
Exclusion Criteria:
* Emergency coronary artery bypass grafting
* On immunosuppression pharmacotherapy
* Pacemaker patients
What they're measuring
1
Inflammation panels in sweat and blood correlated to clinical outcome